BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Link Cell Therapies Begins Phase I Trial of Logic-Gated CAR-T Therapy for Kidney Cancer

LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD ...

September 30, 2026 | News

Hengrui Pharma Inks $2.6B Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Therapy

HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total pot...

September 30, 2026 | News

iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China

Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iReg...

September 30, 2026 | News

Lundbeck Relocates US Headquarters to Greater Boston, Establishes Global Innovation Hub

The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent ...

September 28, 2026 | News

FDA Approves Mirum and Incyte’s Atebrioz for Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz...

September 28, 2026 | News

Earendil Labs, Genentech Ink $1.5B+ Deal to Develop AI-Driven Bispecific Antibodies

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member o...

September 25, 2026 | News

Oracle Unveils AI-Powered Oncology EHR to Transform Cancer Care

Oracle Health and Life Sciences Summit – Oracle today announced its Oracle Health Oncology EHR. Building on the capabilities of Oracle's modern,...

September 25, 2026 | News

Thermo Fisher Launches CHO-K1 Media Panel to Boost Biologics Production

Thermo Fisher Scientific, the world leader in serving science, announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed me...

September 24, 2026 | News

NewAmsterdam, Menarini Secure EU Approval for Obicetrapib-Based Ubeslo and Evlarco

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company developing oral, non-s...

September 23, 2026 | News

Nona Biosciences Develops AI Language Model for Fully Human Heavy-Chain-Only Antibodies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, annou...

September 18, 2026 | News

Takeda’s Zasocitinib Receives US FDA Priority Review for Plaque Psoriasis

-Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for za...

September 16, 2026 | News

Accro Bioscience’s AC-101 Enters China’s Rare Disease Innovative Drug Pilot Programme for Blau Syndrome

Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot Program (the "Caring...

September 15, 2026 | News

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics in Strategic Collaboration

Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, R&D and proce...

September 11, 2026 | News

Evinova, Lothar Medical Partner to Digitise Respiratory Clinical Trials

Evinova, a global leader in AI-native clinical development technology, announced a strategic partnership with Lothar Medical to help transform the ex...

September 08, 2026 | News

Stay Connected